Table 1.

Effect of Anti-FasL and/or Anti-TNFα Antibodies on GVHD-Associated Lymphoid Hypoplasia

MiceCell No. (×107)
H-2Kd+Kb+H-2Kd−Kb+
CD4+CD8+B220+CD4+CD8+B220+
Normal  2.1 ± 0.11  1.5 ± 0.57  2.8 ± 0.80 —  —  —  
GVHD  0.2 ± 0.02  0.2 ± 0.02 0.7 ± 0.06  0.4 ± 0.06  0.3 ± 0.07 1.3 ± 0.60  
Anti-FasL  1.2 ± 0.05  1.7 ± 0.06 1.8 ± 0.33  2.2 ± 0.70  2.5 ± 0.84 1.6 ± 0.52  
Anti-TNFα  1.2 ± 0.46 1.1 ± 0.29  1.4 ± 0.02  2.4 ± 0.30 2.0 ± 0.30  1.9 ± 0.10  
Anti-FasL + anti-TNFα 1.6 ± 0.20  1.9 ± 0.45  2.0 ± 0.65 3.3 ± 0.27  3.3 ± 0.39  2.8 ± 0.90 
MiceCell No. (×107)
H-2Kd+Kb+H-2Kd−Kb+
CD4+CD8+B220+CD4+CD8+B220+
Normal  2.1 ± 0.11  1.5 ± 0.57  2.8 ± 0.80 —  —  —  
GVHD  0.2 ± 0.02  0.2 ± 0.02 0.7 ± 0.06  0.4 ± 0.06  0.3 ± 0.07 1.3 ± 0.60  
Anti-FasL  1.2 ± 0.05  1.7 ± 0.06 1.8 ± 0.33  2.2 ± 0.70  2.5 ± 0.84 1.6 ± 0.52  
Anti-TNFα  1.2 ± 0.46 1.1 ± 0.29  1.4 ± 0.02  2.4 ± 0.30 2.0 ± 0.30  1.9 ± 0.10  
Anti-FasL + anti-TNFα 1.6 ± 0.20  1.9 ± 0.45  2.0 ± 0.65 3.3 ± 0.27  3.3 ± 0.39  2.8 ± 0.90 

Cell numbers of CD4+ T, CD8+ T, and B220+ B cells of host (H-2Kd+Kb+) or donor (H-2Kd−Kb+) origin in the splenocytes from normal CBF1, GVHD, or anti-FasL antibody-treated and/or anti-TNFα antibody-treated mice on day 21 were calculated from the total numbers of splenocytes recovered, and the percentages of each subpopulation were determined using three-color flow cytometric analysis. Data represent the mean ± SD of 5 mice in each group.

Close Modal

or Create an Account

Close Modal
Close Modal